Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Februar 2021 16:01 ET | Quelle: iCAD, Inc.

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020

Fourth Quarter Revenues of $10.5 Million Represented 47% Sequential Growth Driven by 70% Growth in ProFound AI® Product Revenue ProFound AI® Product Revenue Increased 21% in the Fourth Quarter of...
18. Februar 2021 18:56 ET | Quelle: iCAD, Inc.

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

NASHUA, N.H., Feb. 18, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
16. Februar 2021 16:01 ET | Quelle: iCAD, Inc.

iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NASHUA, N.H., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
19. Januar 2021 08:00 ET | Quelle: iCAD, Inc.

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

NASHUA, N.H., Jan. 19, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
06. Januar 2021 16:01 ET | Quelle: iCAD, Inc.

iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

NASHUA, N.H., Jan. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
29. Dezember 2020 17:54 ET | Quelle: iCAD, Inc.

iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption

International Multi-Center Study to Commence January 2021 University of Louisville’s Trial on IORT for Large Brain Lesion Treatments Accelerating First European Patient Treated for Brain Metastasis...
10. Dezember 2020 08:00 ET | Quelle: iCAD, Inc.

Solis Mammography Adopts iCAD’s ProFound AI Platform Powered by Panorama with Short-Term Breast Cancer Risk Assessment Solution

NASHUA, N.H. and DALLAS, Dec. 10, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, and Solis...
03. Dezember 2020 08:00 ET | Quelle: iCAD, Inc.

iCAD Hosting Investor Webinar on Expanded ProFound AI Portfolio with New Breast Cancer Risk Assessment Solution

Leading Clinical Experts Discuss Advancing Personalized Breast Cancer Screening and Detection with Newly Launched ProFound AI Risk Added Market Growth Opportunity Presented by Pioneering AI Breast...
30. November 2020 08:00 ET | Quelle: iCAD, Inc.

iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020

NASHUA, N.H., Nov. 30, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
25. November 2020 08:00 ET | Quelle: iCAD, Inc.

iCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress

NASHUA, N.H., Nov. 25, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...

Vorherige Seite

Nächste Seite